Betahistine hydrochloride
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313416This classification denotes a vasodilating agent with the molecular formula C8H12N2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49K58SMZ7U, chemically known as 2-pyridineethanamine, n-methyl-, dihydrochloride but more generally known as betahistine dihydrochloride, which bears US NIH Compound Identifier 68643. The base compound, Betahistine, most often comes in base, dihydrochloride, hydrochloride, and mesylate forms. European Medicines Agency schedules Betahistine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00772MIG. Most nations, for tariff and trade purposes, schedule betahistine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, BETAHISTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Betahistine hydrochloride bears US NLM identifiers UMLS ID C0282071 and NCI Concept Code C73794. SMILES: CNCCC1CCCCN1.CL.CL.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.